The mission of the Mood Disorders Program is to provide expert, compassionate care for younger and older adults with mood and anxiety disorders. Our services include assessment and treatment, including medication, psychotherapy, and brain stimulation. The Program has a strong research with an emphasis on expanding our understanding of the causes of depression and anxiety disorders. Additionally, we are particularly interested in the relationship between these disorders, aging, and vascular disease. Our hope is that this work will lead to better ways of treating these complex conditions and improving clinical outcomes.
Director: Warren D. Taylor, MD, MHSc
Faculty and Clinicians:
Sonia Beck, PhD
Jonathan Becker, MD
Nathaniel Clark, MD, Director of Brain Stimulation Services
Kirsten Haman, PhD
Stephen Montgomery, MD
Angela Muterspaugh, BA, MMFT
Research efforts are in conjunction with the Vanderbilt Center for Cognitive Medicine. https://medschool.vanderbilt.edu/ccm/
To find out more about current Mood Disorder Program research studies, contact Ms. Maren Henry at 615 322-1101.
Studies Currently Recruiting:
Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression.
Study Description: The study is conducted at Vanderbilt University Medical Center. It involves coming to VUMC for 3-4 visits over 12 weeks and includes: a clinical interview, memory testing, and a brain scan. All participants will receive medication approved for the treatment of depression. You may be eligible if you are age 60 or above, currently depressed, and have no other mental health problems. Participants will be reimbursed up to $250 for their time.
Studies not yet recruiting:
Interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose study of brexpiprazole as adjunctive treatment to paroxetine or sertraline in adult patients suffering from post-traumatic stress disorder (PTSD)